Synthesis of highly fluorescent (E)-Stilbene derivatives containing polysubstituted imidazole scaffold

Synthesis and optical properties of novel 1,2,3-triazole derivatives possessing highly substituted imidazoles

Reactions of 1,4,5-triaryl-2-(4-bromomethyl)phenyl-imidazoles with sodium azide in acetone give the corresponding azidomethyl derivatives, which on 1,3-dipolar cycloaddition with various terminal alkynes in the presence of CuI afford novel 1,2,3-triazole products. On the other hand, treatment of 2,4,5-triaryl-1-(4-hydroxyphenyl)-imidazoles with propargyl chloride in the presence of a base gives the corresponding propargyl ether derivatives, which under CuI-catalyzed 1,3-dipolar cycloaddition with benzyl azide produce 1,2,3-triazole derivatives. All the products are characterized from their spectroscopic data and most are evaluated for fluorescence emission. The optical parameters of the studied products are also reported.

Synthesis and optical studies of Y-shaped imidazole derivatives

A novel series Y-shaped π-expanded imidazole based chromophores was designed and synthesized. The series contains thirteen 2-aryl-4,5-bis[2-(aryl)vinyl)]-1H-imidazoles (6a-6m), which were characterized by spectroscopic analysis. The structures of compounds 6d and 6j were also confirmed by X-ray crystallographic analysis. The optical studies were investigated using absorption and emission measurements in dichloromethane. The fluorescence quantum yields were observed varying in 0.22-0.59 range, but the compounds with nitro substituent did not show the fluorescence. The absorption and emission study of the series helped us to understand the effect of substituents on the optical properties of compounds as well.

DNA-binding affinity, cytotoxicity, apoptosis, cell cycle inhibition and molecular docking studies of a new stilbene derivative

Stilbene derivatives have been found to possess promising anticancer activities against human cancer cell lines in vitro. In the present study, we have investigated cytotoxic, apoptosis induction and DNA binding activity of new stilbene derivative, (E)-1-(4-Chlorophenyl)-4,5-diphenyl-2-[4-(4-methoxystryl)phenyl]-1H-imidazol (STIM) on K562 chronic myeloid leukemia cell line. Via MTT assay STIM demonstrated cytotoxic activity against K562 cell line with IC₅₀ value of 150 µM. Apoptosis, as the mechanism of cell death, was evaluated by morphological study and flow cytometric analysis. In vitro DNA binding property of STIM has been studied by vital spectroscopic techniques, which indicated that STIM interact with ctDNA through groove binding mode and binding constant (K_b) was estimated to be 6.9 × 10⁴ M^-1. Docking studies revealed that hydrophobic is the most important interaction in STIM-DNA complex, and that the ligand (STIM) interacts with DNA via groove binding mode and the bindiyspng energy was calculated as -13.37 kcal/mol. Taken together, the present study suggests that STIM exhibits anticancer effect on K562 cell line through the induction of apoptosis as well as cell cycle arrest at Sub-G1 phase and also can bind to double helix DNA in vitro.